Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076217 · ClinicalTrials.gov registry record
Quick Start of Highly Effective Contraception
A clinical trial of Contraception and IUD, sponsored by University of Utah.
- Active
- Registry status
- 1,030
- Enrollment target
- 1
- Study location
NCT02076217 is a study of Contraception and IUD that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 1,030 participants, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (134% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02076217, a study of Contraception and IUD, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- 1,030 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).
Conditions Studied
Interventions
- DRUG Copper T-380 IUD
- DRUG LNG IUD
- DEVICE Contraceptive implant Nexplanon
- DRUG Depo-Provera
Study Locations (1)
Utah
- Planned Parenthood Association of Utah - West Valley City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,030 participants |
| Start Date | 2014-02 |
| Est. Completion | 2026-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02076217
The ClinicalTrials.gov registry entry for NCT02076217 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,030 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (134% higher). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Contraception appearing as the primary indexed condition, and to 4 interventions - of which Copper T-380 IUD is the first listed.
NCT02076217 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT02076217 about?
NCT02076217 is a clinical study titled "Quick Start of Highly Effective Contraception". This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).
What is the current status of trial NCT02076217?
This trial is currently active not recruiting. The enrollment target is 1,030 participants. The study started on 2014-02. Estimated completion is 2026-01.
What conditions does trial NCT02076217 study?
This clinical trial studies the following conditions: Contraception, IUD, Emergency Contraception, Birth Control, Contraceptive Implant.
What interventions are being tested in trial NCT02076217?
The interventions under investigation include: Copper T-380 IUD (DRUG), LNG IUD (DRUG), Contraceptive implant Nexplanon (DEVICE), Depo-Provera (DRUG).
Who is sponsoring clinical trial NCT02076217?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02076217 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.